Trial Profile
A Multicenter, Phase II, Single-Arm Clinical Trial of nab-Paclitaxel as salvage treatment for patients with Locally Advanced or Metastatic Adenocarcinomas of the Stomach and Gastro-esophageal junction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
- 07 Oct 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 16 Aug 2012 New trial record